FDA considers weekly insulin for diabetics

(CNN)– A U.S. Food and Drug Administration Advisory Committee is considering the benefits of a weekly insulin shot for diabetics.

Most diabetics currently take a daily insulin injection to help manage their blood sugar levels.

Novo Nordisk, the pharmaceutical company that makes a once weekly insulin product is seeking approval from the FDA.

During a meeting on Friday, the FDA advisory committee focused on the safety and efficacy of the weekly insulin product for people with type-one diabetes.

If the insulin product is approved, some committee members said there should be guidance on ways to mitigate and treat the risk of low blood sugar.